Genome-wide transcriptome analysis to further understand neutrophil activation and lncRNA transcript profiles in

Tai-Ming Ko1,2,3, Jeng-Sheng Chang4,5, Shih-Ping Chen1

  • 1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.

Scientific Reports
|January 25, 2019
PubMed

Insights

Kawasaki disease (KD) involves increased CD177 transcripts and a long non-coding RNA, XLOC_006277. XLOC_006277 is linked to coronary artery aneurysms (CAA) and may play a role in KD pathogenesis.

Area of Science:

  • Pediatric Cardiology
  • Molecular Biology
  • Immunology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired pediatric heart disease.
  • The specific transcriptomic alterations in KD, particularly those leading to coronary artery aneurysms (CAA), remain poorly understood.

Purpose of the Study:

  • To identify key transcripts altered in KD patients.
  • To investigate the role of these transcripts in disease progression and CAA development.

Main Methods:

  • Blood samples were collected from 37 KD patients across a time-course.
  • mRNA and long non-coding RNA (lncRNA) profiling was performed.
  • Gene expression levels were analyzed in relation to disease severity and treatment response.

Main Results:

  • CD177 transcript levels were elevated in acute KD and in patients resistant to intravenous immunoglobulin (IVIG).
  • XLOC_006277, a lncRNA, showed significantly higher expression in acute KD and in patients with CAA.
  • XLOC_006277 knockdown reduced the expression of MMP-8 and MMP-9, enzymes implicated in cardiac lesions.

Conclusions:

  • Increased CD177-positive neutrophils are associated with KD.
  • This study provides a global view of lncRNA profiles in KD, offering insights into CAA pathogenesis.
  • XLOC_006277 is a potential biomarker and therapeutic target for KD-associated CAA.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.6K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
25.5K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

10.6K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.7K